Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page footer now shows Revision: v3.6.3 instead of v3.6.2. This is a minor maintenance update to the page's versioning information, with no changes to study content or functionality.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version was deployed. No user-facing content changes are indicated by the data.SummaryDifference0.1%

- Check40 days agoChange DetectedRecruitment status now indicates no longer looking for participants, signaling that enrollment is closed or paused. New helper sections were added (How to Read a Study Record, Common Questions, How to Join a Study) alongside a revised Intervention/Treatment section and a v3.6.0 site revision note.SummaryDifference0.5%

- Check47 days agoChange Detected- The page's revision label updated from v3.5.4 to v3.5.5, indicating a new build/version of the page. - The previous revision label has been replaced by the new one, reflecting an incremental update to the site.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now lists Revision: v3.5.4 instead of v3.5.3, signaling a minor site update. No study content or critical functionality appears to be affected.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page’s footer indicates an update to the ClinicalTrials.gov interface/version (revision v3.5.3 instead of v3.5.2). This reflects a version change of the site rather than an update to the trial details.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.